Breast Cancer

We build your team of breast cancer experts based on your needs, providing personalized, compassionate care.

First, we identify the specific type of breast cancer using microscopic analysis, genetic testing, and imaging. Then, we create an individualized treatment plan for you. At the Breast Cancer Center, part of NYU Langone’s Perlmutter Cancer Center, our experts provide the most advanced treatments, such as breast-conserving surgery and targeted drugs, and our researchers evaluate promising new treatments for breast cancer in clinical trials.

We offer comprehensive support services including fertility preservation counseling, psychological support, and integrative therapies.

We counsel women who are at high risk for developing breast cancer, and our experts frequently provide second opinions.

 

Clinical Trials and Research Studies

Phase 1

Phase 1 Open-Label Multicenter Dose Escalation Study of mRNA-2752 a Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L IL-23 and IL-36? for Intratumoral Injection Alone and in Combination with Immune Checkpoint Blockade

Learn More

Phase 2

A Phase II Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive HER-2 Negative Advanced/Metastatic Breast Cancer Patients: Big Ten Cancer Research Consortium BTCRC-BRE16-042

Learn More

Phase 3

NRG-BR007: A PHASE III CLINICAL TRIAL EVALUATING DE-ESCALATION OF BREAST RADIATION FOR CONSERVATIVE TREATMENT OF STAGE I HORMONE SENSITIVE HER2-NEGATIVE ONCOTYPE RECURRENCE SCORE = 18 BREAST CANCER

Learn More

Phase 2

Phase II Trial of Radium-223 Dichloride in Combination with Paclitaxel in Patients with Bone Metastatic Breast Cancer

Learn More